1. |
夏加增,楊繼昌,張熔熔,等.胃癌中Cyclin D1、 Cyclin E和p27的表達及其意義 [J]. 中國普外基礎與臨床雜志,2001; 8(3)∶148.
|
2. |
郭貴龍,姚榛祥.p27在甲狀腺濾泡狀腫瘤中的表達及其意義 [J]. 中國普外基礎與臨床雜志,2001; 8(5)∶324.
|
3. |
姚旻,周信達,劉銀坤,等. 上皮鈣粘蛋白(Ecadherin)在高侵襲性肝細胞癌中的表達 [J]. 中華消化雜志,1998; 18(1)∶31.
|
4. |
Ito Y, Matsuura N, Sakon M, et al. Expression and prognostic roles of the G1S Modulators in hepatocellular carcinoma: p27 independently predicts the recurrence [J]. Hepatology,1999; 30(1)∶90.
|
5. |
Sgambato A, Cittadini A, Faraglia B, et al. Multiple functions of p27kip1 and its alterations in tumor cells: A review [J]. J Cell Physio,2000; 183(1)∶18.
|
6. |
Pagano M, Tam SW, Theodoras AM, et al. Role of the ubiquitin proteasome pathway in regulating abundance of the cyclindependent kinase inhibitor p27 [J]. Science,1995; 269(5224)∶682.
|
7. |
Ferrando AA, Balbin M, Pendas AM, et al. Mutational analysis of the human cyclin dependent kinase inhibitor p27kip1 in primary breast carcinomas [J]. Hum Genet, 1996; 97(1)∶91.
|
8. |
Hengst L, Reed SI. Translational control of p27kip1accumulation during the cell cycle [J]. Science,1996; 271(5257)∶1861.
|
9. |
Yamamoto H, Soh JW, Shirin H, et al. Comparative effects of overexpression of p27kip1 and p21cip/Waf1 on growth and differentiation in human colon carcinoma cells [J]. Oncogene, 1999; 18(1)∶103.
|
10. |
Levenberg S, Yarden A, Kam Z, et al. p27 is involved in Ncadherinmediated contact inhibition of cell growth and Sphase entry [J]. Oncogene,1999; 18(4)∶869.
|
11. |
Fang F, Orend G, Watanabe N, et al. Dependence of cyclin ECDK2 kinase activity on cell anchorage [J]. Science,1996; 271(5248)∶499.
|